Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cruz Hernandez

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cancer Discovery|December 4, 2019
Oncogenic Drivers and DevelopmentDavid Cruz Hernandez, Paresh Vyas
IUBMB Life|November 27, 2019
GATA1 and cooperating mutations in myeloid leukaemia of Down syndromeCatherine Garnett, David Cruz Hernandez, Paresh Vyas
Nature Protocols|September 22, 2017
Generation and use of a humanized bone-marrow-ossicle niche for hematopoietic xenotransplantation into miceAndreas Reinisch, David Cruz Hernandez, Katharina Schallmoser, et al.
Elife|November 17, 2018
Correction: Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6Rasmus O Bak, Daniel P Dever, Andreas Reinisch, et al.
Elife|September 29, 2017
Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6Rasmus O Bak, Daniel P Dever, Andreas Reinisch, et al.
Blood|June 20, 2020
Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndromeDavid Cruz Hernandez, Marlen Metzner, Anne Pieta de Groot, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 20, 2020
Prostate Cancer Spheroids: A Three-Dimensional Model for Studying Tumor HeterogeneityMauricio Rodríguez-Dorantes, Carlos David Cruz-Hernandez, Sergio Alberto Cortés-Ramírez, et al.
The Journal of Clinical Investigation|August 15, 2023
RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibitionAmy C Fan, Yusuke Nakauchi, Lawrence Bai, et al.
Haematologica|June 13, 2020
Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delayGaëtan Juban, Nathalie Sakakini, Hedia Chagraoui, et al.
Blood|June 25, 2025
Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndromeNatalina Elliott, Neha Bhatnagar, Gemma Buck, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancer Discovery|December 4, 2019
Oncogenic Drivers and DevelopmentDavid Cruz Hernandez, Paresh Vyas
IUBMB Life|November 27, 2019
GATA1 and cooperating mutations in myeloid leukaemia of Down syndromeCatherine Garnett, David Cruz Hernandez, Paresh Vyas
Nature Protocols|September 22, 2017
Generation and use of a humanized bone-marrow-ossicle niche for hematopoietic xenotransplantation into miceAndreas Reinisch, David Cruz Hernandez, Katharina Schallmoser, et al.
Elife|November 17, 2018
Correction: Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6Rasmus O Bak, Daniel P Dever, Andreas Reinisch, et al.
Elife|September 29, 2017
Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6Rasmus O Bak, Daniel P Dever, Andreas Reinisch, et al.
Blood|June 20, 2020
Sensitive, rapid diagnostic test for transient abnormal myelopoiesis and myeloid leukemia of Down syndromeDavid Cruz Hernandez, Marlen Metzner, Anne Pieta de Groot, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 20, 2020
Prostate Cancer Spheroids: A Three-Dimensional Model for Studying Tumor HeterogeneityMauricio Rodríguez-Dorantes, Carlos David Cruz-Hernandez, Sergio Alberto Cortés-Ramírez, et al.
The Journal of Clinical Investigation|August 15, 2023
RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibitionAmy C Fan, Yusuke Nakauchi, Lawrence Bai, et al.
Haematologica|June 13, 2020
Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delayGaëtan Juban, Nathalie Sakakini, Hedia Chagraoui, et al.
Blood|June 25, 2025
Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndromeNatalina Elliott, Neha Bhatnagar, Gemma Buck, et al.
Pageof 2